The business in question is an independent, evidence-based platform specializing in peptide intelligence, offering a comprehensive database of 94 peptides. It provides honest evidence ratings, regulatory status, clinical context, and practical tools aimed at practitioners, researchers, and informed patients. The platform positions itself as a high-quality hub for content and tools within the rapidly expanding peptides and longevity niche. Its business model includes several revenue streams: a free weekly newsletter with strong potential for subscriber growth, a subscription service featuring an AI-powered stacking builder and advanced tools, and a provider directory with tiered paid listings. All monetization features are fully developed and ready for activation. Key operations of the platform focus on low overhead and a content-driven strategy, enabling it to be managed part-time either solo or with a small team. The platform boasts a modern and technically robust website. Its audience consists of medical practitioners, wellness professionals, researchers, and serious self-experimenters seeking reliable peptide information and connections. Although currently pre-revenue, the platform holds significant growth and monetization potential with its existing features. Growth opportunities include increasing directory listings and subscriptions, enhancing SEO/content marketing, expanding the newsletter and paid ads, and forming partnerships or premium content offerings. The platform is ready to transition to a buyer who can focus on its growth and monetization potential. The current owner seeks to sell in order to pass the opportunity to someone who can enhance its market position further.